Literature DB >> 9228481

Pulmonary disposition of vancomycin in critically ill patients.

H Georges1, O Leroy, S Alfandari, B Guery, M Roussel-Delvallez, C Dhennain, G Beaucaire.   

Abstract

Vancomycin penetration in epithelium lining fluid was studied in ten mechanically ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia 24 hours after the onset of treatment. Vancomycin was given intravenously at a daily dose of 30 mg/kg. Vancomycin levels were detectable in four patients (range, 1-2.77 micrograms/ml). Concordance between high plasma concentrations (> 20 micrograms/ml) and detectable vancomycin levels in epithelium lining fluid was noted. These results suggest that the pulmonary disposition of vancomycin remains low for most patients 24 h after the onset of treatment compared with the minimum inhibitory concentrations for most gram-positive organisms. One therapeutic goal of vancomycin treatment could be to obtain through plasma levels of 20 micrograms/ml. Further studies are required to determine the clinical relevance of these observations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228481     DOI: 10.1007/bf01726369

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  An expanded definition of the adult respiratory distress syndrome.

Authors:  J F Murray; M A Matthay; J M Luce; M R Flick
Journal:  Am Rev Respir Dis       Date:  1988-09

3.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

Review 4.  Vancomycin administration and monitoring reappraisal.

Authors:  N J Saunders
Journal:  J Antimicrob Chemother       Date:  1995-08       Impact factor: 5.790

Review 5.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

6.  Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients.

Authors:  C Lamer; V de Beco; P Soler; S Calvat; J Y Fagon; M C Dombret; R Farinotti; J Chastre; C Gibert
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

7.  Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.

Authors:  J Rello; A Torres; M Ricart; J Valles; J Gonzalez; A Artigas; R Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405

8.  Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.

Authors:  B F Farber; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  A prospective study of adverse reactions associated with vancomycin therapy.

Authors:  T C Sorrell; P J Collignon
Journal:  J Antimicrob Chemother       Date:  1985-08       Impact factor: 5.790

10.  Effect of intravenous vancomycin on renal function.

Authors:  R H Eng; L Wynn; S M Smith; F Tecson-Tumang
Journal:  Chemotherapy       Date:  1989       Impact factor: 2.544

View more
  15 in total

1.  Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design.

Authors:  Konstantinos Z Vardakas; Michael N Mavros; Nikolaos Roussos; Matthew E Falagas
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

2.  Traditional weight-based vancomycin dosing is inadequate in critically ill trauma patients.

Authors:  D D Yeh; M E Kutcher; K Lunghi
Journal:  Eur J Trauma Emerg Surg       Date:  2011-11-15       Impact factor: 3.693

3.  Telavancin penetration into human epithelial lining fluid determined by population pharmacokinetic modeling and Monte Carlo simulation.

Authors:  Thomas P Lodise; Mark Gotfried; Steven Barriere; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2008-04-21       Impact factor: 5.191

4.  Penetration of vancomycin into epithelial lining fluid in healthy volunteers.

Authors:  Thomas P Lodise; George L Drusano; Jill M Butterfield; Joshua Scoville; Mark Gotfried; Keith A Rodvold
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

Review 5.  Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.

Authors:  Keith A Rodvold; Jomy M George; Liz Yoo
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

6.  Impact of administration of vancomycin or linezolid to critically ill patients with impaired renal function.

Authors:  O Rodriguez Colomo; F Álvarez Lerma; M I González Pérez; J-M Sirvent; M García Simón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-12       Impact factor: 3.267

Review 7.  Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections.

Authors:  Christopher Giuliano; Christopher Giulano; Krystal K Haase; Ronald Hall
Journal:  Expert Rev Anti Infect Ther       Date:  2010-01       Impact factor: 5.091

Review 8.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

9.  Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.

Authors:  Marin H Kollef; Jordi Rello; Sue K Cammarata; Rodney V Croos-Dabrera; Richard G Wunderink
Journal:  Intensive Care Med       Date:  2004-01-09       Impact factor: 17.440

10.  Influence of Mechanical Ventilation on the Pharmacokinetics of Vancomycin Administered by Continuous Infusion in Critically Ill Patients.

Authors:  Susanna Edith Medellín-Garibay; Silvia Romano-Moreno; Pilar Tejedor-Prado; Noelia Rubio-Álvaro; Aida Rueda-Naharro; Miguel Angel Blasco-Navalpotro; Benito García; Emilia Barcia
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.